Completed Infection & Immunity Food & Agriculture

The Molecular Biology of FMDV Replication: Towards New Methods of FMDV Disease Control.

In plain English

AI plain-English summary

Foot-and-mouth disease virus (FMDV) is rewriting its own genetic code to become a safer, more effective vaccine. The virus is the most contagious mammalian pathogen known, and current killed-virus vaccines are limited in their ability to control both disease and transmission. The 2001 UK outbreak cost billions of pounds and required the slaughter of millions of animals, a policy that proved deeply unpopular. This research aims to develop two new vaccine strategies. The first uses modern molecular biology to create live-attenuated viruses—weakened strains that trigger a superior immune response without causing disease, similar to the polio vaccine that has brought global eradication within reach. The second strategy engineers a virus that can only grow in specially designed "helper" cells, making conventional killed-vaccine production far safer. If successful, either approach could make routine vaccination against FMDV practical worldwide, reducing the global incidence of the disease. This would protect livestock productivity and food security, particularly in developing economies where rising meat demand is straining agricultural systems. The research is fundamental molecular biology, but with a clear applied goal: replacing a controversial culling policy with a viable vaccinate-to-live strategy.

View original technical description
One of our biggest challenges will be to meet a growing demand for food, especially in the developing world and economies such as India and China where the demand for meat products is rising. Animal diseases have a major impact on the productivity of the livestock industry and safeguarding animal welfare will be a major component of maximising food production. Foot-and-mouth disease virus (FMDV) is an animal pathogen which infects domesticated animals (cattle, sheep, goats and pigs). It is probably the most contagious mammalian virus known and much feared as the virus can spread extremely rapidly. The virus can also cause long-term 'persistent' infections that are in apparent; they are difficult to diagnose in the field and complicate disease control. FMDV can also infect many species of wildlife, and in Africa persistent infections in wildlife provides an important reservoir that may infect domestic livestock. FMDV causes disease around the globe and is a continual threat to UK agriculture via the import of contaminated animals and animal products. Infection is rarely fatal, but it can have a dramatic impact upon the productivity of farm animals. The 2001 UK outbreak caused massive economic damage (billions of pounds) due to lost trade and impact upon farming communities. In addition, control of the disease through the slaughter of infected and high-risk animals was highly controversial and unpopular and led to heightened interest in a "vaccinate to-live policy". Vaccines are often of two types. The first are inactivated or 'killed' viruses which cannot infect the host but still prime the immune system to protect against later infection. The second are live viruses which are weakened or 'attenuated': they do infect the host thus triggering a superior immune response but are not strong enough to cause disease. Current vaccines for FMDV are only of the 'killed' type. In contrast, for the closely related human virus poliovirus, live 'attenuated' vaccines have been used to effectively control both disease and transmission such that global eradication of poliovirus is within sight. The effectiveness of current 'killed' vaccines for FMDV are limited by a number of factors and there is an urgent need to develop new control measures: we therefore wish to develop novel 'attenuated' vaccines, one of the goals of this research. To do this safely will require a detailed understanding of the complex interactions between FMDV and its host. Our proposed research will give novel insight into how FMDV interacts with its host-cell to achieve rapid replication or establish persistent infections. We will use this information to improve the effectiveness and safety of vaccines. The first strategy is to use modern molecular biology to change the virus, to make new strains that can protect animals without causing the debilitating disease - so-called live-attenuated viruses. The second strategy is to use the knowledge of how the virus grows in cells to make a new type of virus that could only grow in special 'helper' cells we will also create. Such viruses will not be able to grow in an animal and cause disease. This would make conventional 'killed' vaccine production a much safer process. Success in either approach would stimulate the routine use of vaccine to control FMDV around the globe. In the longer term, this could make a difference by reducing the overall, global incidence of FMD with enormous economic and social value worldwide. We argue that better control of FMD is essential for food security and must be coupled with the development of new vaccines, or new methods of producing vaccines, to make this policy effective. This is the purpose of our research.

View the original record at the funder ↗

Researchers

Angus Lamond (Co-Investigator)David Rowlands (Co-Investigator)Donald King (Co-Investigator)Jurgen Haas (Co-Investigator)Martin Ryan (Principal Investigator)Nicola Jane Stonehouse (Co-Investigator)Terry Jackson (Co-Investigator)Tobias Tuthill (Co-Investigator)

Related Research

Grants with similar aims, by meaning.

Attenuation of FMDV Serotypes/Strains to Develop Stable and Effective Live, Attenuated, Vaccines
Improved vaccine manufacture to control foot-and-mouth disease: Production of recombinant vaccines by design
Improved control of endemic foot-and-mouth disease by development of virus like particle vaccines
Subversion of ER exit sites for FMDV replication
Translation of virus like particle foot-and-mouth disease vaccine research to commercial development

Original classification

Research Grant

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.